Skip to main content

May 14, 2024

Nova Revalidated through the Validation Institute

Validation affirms Nova’s clinical programs produce improved health outcomes

Nova Healthcare Administrators, Inc. (Nova) was recently revalidated through the Validation Institute for 2024 in the common chronic condition management category. The validation comes after a thorough data analysis that confirms Nova’s clinical protocols drive measurable improvements in health plan trend.

“This award is important to Nova because its external confirmation of the efficacy of Nova’s programs for clients and their plan participants,” said Jim Walleshauser, president, Nova. “It stands as a testament to the dedicated efforts and collaborative spirit of our team members across medical management, care navigation, data analytics, and client services. At Nova, our overarching goal is to simplify the complexities of the health care system for insurance brokers, clients, and their members. This validation unequivocally reaffirms our commitment to delivering on our promises within the industry.”

Nova creates a cost and risk management strategy tailored to our clients’ goals. Our approach includes analyzing medical, behavioral and pharmacy claims, plus operational observations, and clinical data. Using this data, Nova works with clients to develop strategies that address preventive care, early detection of illness, improving treatment compliance and appropriateness of services. Based on 2023 data, Nova has once again achieved below-average admissions and emergency room visits for common chronic diseases (asthma, coronary artery disease, congestive heart failure, hypertension, COPD, and diabetes), compared to a national benchmark.

“While all event rates fell in 2020-2021, Nova’s declined more than most and did not increase as much in 2023 and 2024,” noted Al Lewis, co-founder of Validation Institute and CEO of Quizzify. “A nice performance as usual!”

Nova’s demographics, claims data, and study design methodology were reviewed, earning Validation Institute’s $50,000 “Credibility Guarantee,” for the outcomes and savings achieved through our chronic condition management program. Nova has received validation through the Validation Institute since 2018. For more information, visit